Zhitong Finance App News, Jianyou Co., Ltd. (603707.SH) announced that Meitheal Pharmaceuticals Inc., a subsidiary of the company, recently received approval for amikacin sulfate injections (500mg/2mL (250mg/mL) and 1g/4mL (250mg/mL)) issued by the US Food and Drug Administration (“US FDA”) to increase the production site, and approved production at the Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.